[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368783-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368783-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","regulation-of-cisplatin-resistance-in-lung-cancer-by-epigenetic-mechanisms","Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms","","Lung cancer is among the most prevalent and lethal malignancies worldwide, causing millions of deaths annually. Cisplatin is an effective anticancer drug and a key component of adjuvant chemotherapy, yet treatment failure often arises from cisplatin resistance. This review summarizes how resistance is driven by impaired DNA repair, suppressed apoptosis, and epigenetic regulation, including DNA methylation, histone modifications, and noncoding RNA control of gene expression and signaling. It highlights recent findings and potential strategies to overcome resistance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/regulation-of-cisplatin-resistance-in-lung-cancer-by-epigenetic-mechanisms/368783/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/regulation-of-cisplatin-resistance-in-lung-cancer-by-epigenetic-mechanisms/368783.png","ImageObject",300,407,{"name":42,"@type":43},"Grenda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-09","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why does cisplatin resistance limit lung cancer treatment?","Question",{"text":63,"@type":64},"Cisplatin resistance leads to treatment failure, reducing cisplatin’s clinical utility and therapeutic efficacy despite optimized chemotherapy regimens.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which epigenetic mechanisms are highlighted as mediators of resistance?",{"text":68,"@type":64},"The review focuses on DNA methylation, histone modifications, and noncoding RNA regulation that modulate gene expression and signaling pathways.",{"name":70,"@type":61,"acceptedAnswer":71},"What other biological mechanisms besides epigenetics contribute to cisplatin resistance?",{"text":72,"@type":64},"It discusses impaired DNA repair pathways and inhibition of apoptosis as additional mechanisms involved in resistance development.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368783,1790481094,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":33,"preview_urls":146},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Yu et al. Clinical Epigenetics (2025) 17:145 [https://doi.org/10.1186/s13148-025-01961-6](https://doi.org/10.1186/s13148-025-01961-6)  \nClinical Epigenetics  \n REVIEW Open Access  \nRegulation of cisplatin resistance in lung cancer by epigenetic mechanisms  \nXiaoyan Yu1, Luyu Jia1, Qing Tang2, Qichun Zhou2, Genshu Wang3* and Sumei Wang2*  \nAbstract  \nLung cancer remains one of the most prevalent and lethal malignancies worldwide, responsible for nearly 1.8 million deaths annually, which accounts for approximately 18 . 7% of global cancer-related mortality. Cisplatin, a highly effective and widely utilized anticancer drug, is particularly effective against solid tumors and serves as a cornerstone of adjuvant chemotherapy for lung cancer. Despite continuous optimization of cisplatin-based chemotherapy regimens, the emergence of cisplatin resistance frequently results in treatment failure, significantly limiting its clinical utility and therapeutic efficacy. To address this challenge, researchers have extensively investigated the biological mechanisms underlying cisplatin resistance, including impaired DNA repair pathways and inhibition of apoptosis. Among these mechanisms, epigenetic regulation—encompassing DNA methylation, histone modifications, and noncoding RNA (ncRNA) regulation—has emerged as a critical factor in mediating cisplatin resistance by modulating gene expression and signaling pathways. This review comprehensively explores the role of epigenetic mechanisms in cisplatin resistance in lung cancer, highlighting recent research findings and their potential implications for developing strategies to overcome drug resistance.  \nKeywords Lung cancer, Cisplatin resistance, Epigenetic regulation, DNA methylation, Noncoding RNA  \n*Correspondence: Genshu Wang [wgsh168@163.com](wgsh168@163.com)[ ](wgsh168@163.com)Sumei Wang  \n[wangsumei198708@163.com](wangsumei198708@163.com)  \n1 The Second Clinical Medical College of Guangzhou, University of Chinese Medicine, Guangzhou, Guangdong 510120, People’s Republic of China  \n2 Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, Department of Oncology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Chinese Medicine Guangdong Laboratory, State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangdong Provincial Key Laboratory of Clinical Research On Traditional Chinese Medicine Syndrome, Guangzhou 510120, Guangdong, China  \n3 State Key Laboratory of Traditional Chinese Medicine Syndrome; Department of Liver transplant and Surgery of Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Engineering Research Center of Precicion Intelligent Surgical Equipment, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China  \nIntroduction  \nLung cancer is one of the most prevalent and deadly malignancies worldwide, with high morbidity and mortality rates primarily attributed to risk factors such as smoking, air pollution, and genetic predisposition. According to recent global statistics, lung cancer accounts for approximately 12.4% of all cancer cases, with nearly 2.5 million new cases diagnosed annually [1] . Lung cancer is broadly classified into two main types: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) . NSCLC, which constitutes about 85% of all lung cancer cases, is the most common form and includes subtypes such as squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. In contrast, SCLC, representing approximately 15% of cases, is less common but more aggressive, often associated with a poorer prognosis [2] . Lung cancer is frequently characterized by an insidious onset, with the majority of NSCLC patients diagnosed at advanced or metastatic stages. Despite significant advancements  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoD","cbCaioiVJK7O9CbA","https://ap.wps.com/l/cbCaioiVJK7O9CbA","pdf",1215742,16,"English","# Introduction\n## Cisplatin and the problem of resistance\n## Epigenetic mechanisms in resistance\n# Conclusion and implications","[{\"question\":\"Why does cisplatin resistance limit lung cancer treatment?\",\"answer\":\"Cisplatin resistance leads to treatment failure, reducing cisplatin’s clinical utility and therapeutic efficacy despite optimized chemotherapy regimens.\"},{\"question\":\"Which epigenetic mechanisms are highlighted as mediators of resistance?\",\"answer\":\"The review focuses on DNA methylation, histone modifications, and noncoding RNA regulation that modulate gene expression and signaling pathways.\"},{\"question\":\"What other biological mechanisms besides epigenetics contribute to cisplatin resistance?\",\"answer\":\"It discusses impaired DNA repair pathways and inhibition of apoptosis as additional mechanisms involved in resistance development.\"}]","Regulation of cisplatin resistance in lung cancer by epigenetic mechanisms | PDF",1790178516,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b154f0e4c8beb1b0f74575b26d2d5626.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2672afc5c9d783a4327e2096a86c78a3.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e5273023b8ed1d03dc8fa653b5c18cbb.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f07eaebe245c7033cdd4ff3d8e2583b3.webp",980,1301]